JOHN F MILLIGAN Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN F MILLIGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN F MILLIGAN. JOHN F MILLIGAN is COO in GILEAD SCIENCES INC ($GILD) and COO and CFO in GILEAD SCIENCES INC ($GILD) and EVP, Chief Financial Officer in GILEAD SCIENCES INC ($GILD) and EVP, COO and CFO in GILEAD SCIENCES INC ($GILD) and President and CEO in GILEAD SCIENCES INC ($GILD) and President and COO in GILEAD SCIENCES INC ($GILD) and President, COO and Director in GILEAD SCIENCES INC ($GILD) and Director in PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ($PACB) and Director in 4D Molecular Therapeutics Inc. ($FDMT).
JOHN F MILLIGAN in GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN F MILLIGAN: President and CEO, President, COO and Director, President and COO, EVP, COO and CFO, COO and CFO, EVP, Chief Financial Officer
Holdings: 1,574,306 shares
Current Value: $115,128,998
Latest Transaction: Nov 29 2018
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN F MILLIGAN in GILEAD SCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FDMT, GILD, PACB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 23.60 | 280,000 | 6,608,000 | 0 | |
| Nov 29 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 23.60 | 280,000 | 6,608,000 | 1,574,306 | 1.3 M to 1.6 M (+21.63 %) |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 27.07 | 80,000 | 2,165,600 | 0 | |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 27.07 | 80,000 | 2,165,600 | 1,294,306 | 1.2 M to 1.3 M (+6.59 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Payment of Exercise | F | 80.69 | 8,009 | 646,246 | 1,214,306 | 1.2 M to 1.2 M (-0.66 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 7,709 | 0 | 1,222,315 | 1.2 M to 1.2 M (+0.63 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 48,342 | 0 | 1,214,606 | 1.2 M to 1.2 M (+4.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 62.35 | 340 | 21,198 | 1,166,264 | 1.2 M to 1.2 M (+0.03 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | A | 83.49 | 295,660 | 24,684,653 | 295,660 | |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 21.58 | 220,000 | 4,746,500 | 0 | |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 72.88 | 220,000 | 16,034,678 | 1,165,924 | 1.4 M to 1.2 M (-15.87 %) |
| Nov 15 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 21.58 | 220,000 | 4,746,500 | 1,385,924 | 1.2 M to 1.4 M (+18.87 %) |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 21.58 | 100,000 | 2,157,500 | 220,000 | |
| Feb 27 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 21.58 | 100,000 | 2,157,500 | 1,165,924 | 1.1 M to 1.2 M (+9.38 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Payment of Exercise | F | 70.31 | 8,389 | 589,831 | 1,065,924 | 1.1 M to 1.1 M (-0.78 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 3,429 | 0 | 1,074,313 | 1.1 M to 1.1 M (+0.32 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 11,606 | 0 | 1,070,884 | 1.1 M to 1.1 M (+1.10 %) |
| Feb 21 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 59.33 | 315 | 18,689 | 1,059,278 | 1.1 M to 1.1 M (+0.03 %) |
| Feb 06 2017 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | A | 72.25 | 325,000 | 23,481,250 | 325,000 | |
| Sep 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 0 | |
| Sep 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 77.74 | 70,000 | 5,442,080 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Sep 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 20.74 | 70,000 | 1,451,800 | 70,000 | |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 70.94 | 70,000 | 4,965,590 | 1,058,963 | 1.1 M to 1.1 M (-6.20 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Aug 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 20.74 | 70,000 | 1,451,800 | 1,128,963 | 1.1 M to 1.1 M (+6.61 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 0 | |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.97 | 8,630 | 733,301 | 1,058,963 | 1.1 M to 1.1 M (-0.81 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 84.28 | 103,370 | 8,711,620 | 1,067,593 | 1.2 M to 1.1 M (-8.83 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jul 07 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 112,000 | |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 87.26 | 59,181 | 5,164,069 | 1,058,963 | 1.1 M to 1.1 M (-5.29 %) |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 86.57 | 52,819 | 4,572,710 | 1,118,144 | 1.2 M to 1.1 M (-4.51 %) |
| Jun 08 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 224,000 | |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 88.14 | 57,329 | 5,052,789 | 1,058,963 | 1.1 M to 1.1 M (-5.14 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 87.27 | 54,671 | 4,771,166 | 1,116,292 | 1.2 M to 1.1 M (-4.67 %) |
| May 04 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 336,000 | |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 94.88 | 15,836 | 1,502,444 | 1,058,963 | 1.1 M to 1.1 M (-1.47 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Sell | S | 94.54 | 96,164 | 9,091,460 | 1,074,799 | 1.2 M to 1.1 M (-8.21 %) |
| Apr 05 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Option Exercise | M | 16.40 | 112,000 | 1,836,240 | 448,000 | |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Sell | S | 87.79 | 112,000 | 9,832,995 | 1,058,963 | 1.2 M to 1.1 M (-9.56 %) |
| Mar 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Buy | M | 16.40 | 112,000 | 1,836,240 | 1,170,963 | 1.1 M to 1.2 M (+10.58 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Payment of Exercise | F | 91.15 | 45,433 | 4,141,218 | 1,058,963 | 1.1 M to 1.1 M (-4.11 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Grant | A | 0.00 | 58,794 | 0 | 1,104,396 | 1 M to 1.1 M (+5.62 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Grant | A | 0.00 | 16,246 | 0 | 1,045,602 | 1 M to 1 M (+1.58 %) |
| Feb 18 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President, COO and ... | Grant | A | 76.02 | 248 | 18,854 | 1,029,356 | 1 M to 1 M (+0.02 %) |
| Feb 03 2016 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | A | 84.05 | 235,820 | 19,820,671 | 235,820 | |
| Dec 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 0 | |
| Dec 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 103.56 | 39,355 | 4,075,490 | 1,029,108 | 1.1 M to 1 M (-3.68 %) |
| Dec 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 102.94 | 60,645 | 6,242,487 | 1,068,463 | 1.1 M to 1.1 M (-5.37 %) |
| Dec 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 100,000 | |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 108.27 | 8,509 | 921,267 | 1,029,108 | 1 M to 1 M (-0.82 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 107.60 | 91,491 | 9,844,377 | 1,037,617 | 1.1 M to 1 M (-8.10 %) |
| Nov 12 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 200,000 | |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 99.93 | 34,151 | 3,412,709 | 1,029,108 | 1.1 M to 1 M (-3.21 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 99.08 | 50,799 | 5,033,368 | 1,063,259 | 1.1 M to 1.1 M (-4.56 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 98.04 | 15,050 | 1,475,446 | 1,114,058 | 1.1 M to 1.1 M (-1.33 %) |
| Oct 08 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 300,000 | |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 103.39 | 100,000 | 10,338,730 | 1,029,108 | 1.1 M to 1 M (-8.86 %) |
| Sep 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Aug 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 400,000 | |
| Aug 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 115.28 | 3,100 | 357,363 | 1,029,108 | 1 M to 1 M (-0.30 %) |
| Aug 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.44 | 22,111 | 2,530,480 | 1,032,208 | 1.1 M to 1 M (-2.10 %) |
| Aug 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 113.74 | 74,789 | 8,506,104 | 1,054,319 | 1.1 M to 1.1 M (-6.62 %) |
| Aug 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 500,000 | |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 116.38 | 300 | 34,915 | 1,029,108 | 1 M to 1 M (-0.03 %) |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 115.74 | 25,315 | 2,930,026 | 1,029,408 | 1.1 M to 1 M (-2.40 %) |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.76 | 22,720 | 2,607,388 | 1,054,723 | 1.1 M to 1.1 M (-2.11 %) |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 113.65 | 51,665 | 5,871,748 | 1,077,443 | 1.1 M to 1.1 M (-4.58 %) |
| Jul 09 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 600,000 | |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.65 | 4,250 | 487,280 | 1,029,108 | 1 M to 1 M (-0.41 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 114.03 | 95,750 | 10,918,133 | 1,033,358 | 1.1 M to 1 M (-8.48 %) |
| Jun 10 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 14.50 | 100,000 | 1,450,250 | 700,000 | |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 101.94 | 15,951 | 1,626,029 | 1,029,108 | 1 M to 1 M (-1.53 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 101.03 | 57,310 | 5,789,829 | 1,045,059 | 1.1 M to 1 M (-5.20 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 100.39 | 26,739 | 2,684,304 | 1,102,369 | 1.1 M to 1.1 M (-2.37 %) |
| May 11 2015 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 14.50 | 100,000 | 1,450,250 | 1,129,108 | 1 M to 1.1 M (+9.72 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 8.22 | 26,720 | 219,606 | 209,120 | |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 8.58 | 33,280 | 285,586 | 0 | |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 54.83 | 200 | 10,966 | 221,489 | 221.7 K to 221.5 K (-0.09 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 54.78 | 402 | 22,022 | 221,689 | 222.1 K to 221.7 K (-0.18 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 54.74 | 59,298 | 3,245,973 | 222,091 | 281.4 K to 222.1 K (-21.07 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 54.73 | 100 | 5,473 | 281,389 | 281.5 K to 281.4 K (-0.04 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 8.22 | 26,720 | 219,606 | 281,489 | 254.8 K to 281.5 K (+10.49 %) |
| Jun 03 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 8.58 | 33,280 | 285,586 | 254,769 | 221.5 K to 254.8 K (+15.03 %) |
| May 09 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | A | 54.14 | 40,000 | 2,165,600 | 40,000 | |
| Mar 19 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Payment of Exercise | F | 47.55 | 6,404 | 304,510 | 221,489 | 227.9 K to 221.5 K (-2.81 %) |
| Mar 19 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Grant | A | 0.00 | 14,000 | 0 | 227,893 | 213.9 K to 227.9 K (+6.55 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Option Exercise | M | 8.58 | 60,000 | 514,878 | 33,280 | |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.50 | 3,000 | 145,500 | 213,893 | 216.9 K to 213.9 K (-1.38 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.35 | 3,000 | 145,050 | 216,893 | 219.9 K to 216.9 K (-1.36 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.15 | 5,000 | 240,750 | 219,893 | 224.9 K to 219.9 K (-2.22 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.13 | 1,500 | 72,195 | 224,893 | 226.4 K to 224.9 K (-0.66 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.80 | 3,000 | 143,400 | 226,393 | 229.4 K to 226.4 K (-1.31 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.75 | 2,500 | 119,375 | 229,393 | 231.9 K to 229.4 K (-1.08 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.70 | 3,000 | 143,100 | 231,893 | 234.9 K to 231.9 K (-1.28 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.55 | 2,000 | 95,100 | 234,893 | 236.9 K to 234.9 K (-0.84 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.40 | 2,000 | 94,800 | 236,893 | 238.9 K to 236.9 K (-0.84 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.60 | 3,000 | 142,800 | 238,893 | 241.9 K to 238.9 K (-1.24 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.82 | 1,000 | 47,820 | 241,893 | 242.9 K to 241.9 K (-0.41 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.03 | 1,000 | 48,030 | 242,893 | 243.9 K to 242.9 K (-0.41 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.07 | 1,000 | 48,070 | 243,893 | 244.9 K to 243.9 K (-0.41 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.27 | 1,000 | 48,270 | 244,893 | 245.9 K to 244.9 K (-0.41 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.10 | 2,000 | 96,200 | 245,893 | 247.9 K to 245.9 K (-0.81 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.17 | 1,000 | 48,170 | 247,893 | 248.9 K to 247.9 K (-0.40 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.20 | 2,000 | 96,400 | 248,893 | 250.9 K to 248.9 K (-0.80 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.33 | 2,000 | 96,660 | 250,893 | 252.9 K to 250.9 K (-0.79 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.30 | 3,000 | 144,900 | 252,893 | 255.9 K to 252.9 K (-1.17 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.05 | 4,000 | 192,200 | 255,893 | 259.9 K to 255.9 K (-1.54 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 48.00 | 13,000 | 624,000 | 259,893 | 272.9 K to 259.9 K (-4.76 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Sell | S | 47.88 | 1,000 | 47,880 | 272,893 | 273.9 K to 272.9 K (-0.37 %) |
| Mar 05 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO and CFO | Buy | M | 8.58 | 60,000 | 514,878 | 273,893 | 213.9 K to 273.9 K (+28.05 %) |
| Feb 01 2008 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, COO and CFO | Option Exercise | A | 43.15 | 160,000 | 6,904,000 | 160,000 | |
| Dec 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Option Exercise | M | 3.70 | 6,500 | 24,071 | 17,020 | |
| Dec 26 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Buy | M | 3.70 | 6,500 | 24,071 | 213,893 | 207.4 K to 213.9 K (+3.13 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Option Exercise | M | 8.58 | 60,000 | 514,878 | 93,280 | |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.28 | 1,000 | 46,280 | 207,393 | 208.4 K to 207.4 K (-0.48 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.31 | 1,000 | 46,310 | 208,393 | 209.4 K to 208.4 K (-0.48 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.45 | 5,000 | 232,250 | 209,393 | 214.4 K to 209.4 K (-2.33 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.40 | 5,000 | 232,000 | 214,393 | 219.4 K to 214.4 K (-2.28 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.35 | 2,000 | 92,700 | 219,393 | 221.4 K to 219.4 K (-0.90 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.38 | 3,000 | 139,140 | 221,393 | 224.4 K to 221.4 K (-1.34 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.25 | 5,000 | 231,250 | 224,393 | 229.4 K to 224.4 K (-2.18 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.22 | 3,000 | 138,660 | 229,393 | 232.4 K to 229.4 K (-1.29 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.18 | 2,000 | 92,360 | 232,393 | 234.4 K to 232.4 K (-0.85 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.20 | 3,500 | 161,700 | 234,393 | 237.9 K to 234.4 K (-1.47 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.13 | 2,500 | 115,325 | 237,893 | 240.4 K to 237.9 K (-1.04 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.10 | 3,500 | 161,350 | 240,393 | 243.9 K to 240.4 K (-1.44 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.03 | 1,000 | 46,030 | 243,893 | 244.9 K to 243.9 K (-0.41 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.02 | 1,000 | 46,020 | 244,893 | 245.9 K to 244.9 K (-0.41 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 46.00 | 2,000 | 92,000 | 245,893 | 247.9 K to 245.9 K (-0.81 %) |
| Dec 05 2007 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | COO | Sell | S | 45.95 | 1,000 | 45,950 | 247,893 | 248.9 K to 247.9 K (-0.40 %) |